1. ICOS accepts Lilly's sweetened takeover offer
- Author
-
Vuocolo, Jonathan
- Subjects
Eli Lilly and Co. -- Mergers, acquisitions and divestments ,ICOS Corp. -- Mergers, acquisitions and divestments ,Biotechnology industry -- Mergers, acquisitions and divestments ,Pharmaceutical industry -- Mergers, acquisitions and divestments ,Company acquisition/merger ,Banking, finance and accounting industries ,Business ,Business, international - Abstract
Eli Lilly and Co. of the United State is to acquire ICOS Corp. also of the United States for $2.3 billion or $34 per share. ICOS Corp. and Eli Lilly and Co. through a joint venture are marketing the erectile-dysfunction drug Cialis. Projected sales for the drug are $965 million in 2006.
- Published
- 2006